分子量マーカーの世界市場

◆英語タイトル:Global Molecular Weight Marker Market 2020-2024
◆商品コード:IRTNTR40304
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年2月28日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートは分子量マーカーの世界市場について調査・分析し、エグゼクティブサマリー、レポートの範囲、市場環境、市場規模、ファイブフォース分析、製品別(DNAマーカー、タンパク質マーカー、RNAマーカー)分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリ
・レポートの範囲
・市場環境
・市場規模
・ファイブフォース分析
・分子量マーカーの世界市場:製品別(DNAマーカー、タンパク質マーカー、RNAマーカー)
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因・課題
・市場動向
・企業状況
・企業分析
【レポートの概要】

Global Molecular Weight Marker Market 2020-2024
Technavio has been monitoring the global molecular weight marker market and it is poised to grow by USD 307.59 mn during 2020-2024, progressing at a CAGR of 12% during the forecast period. Our reports on global molecular weight marker market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by significant use of sds-page in therapeutic discoveries and developments. In addition, emergence of microfluidic chip electrophoresis is anticipated to boost the growth of the global molecular weight marker market as well.

Market Segmentation
Technavio’s global molecular weight marker market is segmented as below:

Product
DNA Marker
Protein Marker
RNA Marker
Geographic segmentation
Asia
Europe
North America
ROW
Key Trends for global molecular weight marker market growth
This study identifies emergence of microfluidic chip electrophoresis as the prime reasons driving the global molecular weight marker market growth during the next few years.

Prominent vendors in global molecular weight marker market
We provide a detailed analysis of around 25 vendors operating in the global molecular weight marker market, including some of the vendors such as Abcam Plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Takara Bio Inc. and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/Global-Molecular-Weight-Market-Market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

01: EXECUTIVE SUMMARY
PART02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Currency conversion rates for US$
03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis
04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• DNA marker – Market size and forecast 2019-2024
• Protein marker – Market size and forecast 2019-2024
• RNA marker – Market size and forecast 2019-2024
• Market opportunity by product
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
11: MARKET TRENDS
• Availability of improved molecular weight markers
• Emergence of microfluidic chip electrophoresis
• Focus on reuse of molecular weight markers for cost-effective gel
• electrophoresis
12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abcam Plc
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• New England Biolabs Inc.
• Promega Corp.
• QIAGEN NV
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
15: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: DNA marker – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: DNA marker – Year-over-year growth 2020-2024 (%)
Exhibit 22: Protein marker – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Protein marker – Year-over-year growth 2020-2024 (%)
Exhibit 24: RNA marker – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: RNA marker – Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America – Year-over-year growth 2020-2024 (%)
Exhibit 32: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc – Vendor overview
Exhibit 47: Abcam Plc – Business segments
Exhibit 48: Abcam Plc – Organizational developments
Exhibit 49: Abcam Plc – Geographic focus
Exhibit 50: Abcam Plc – Key offerings
Exhibit 51: Agilent Technologies Inc. – Vendor overview
Exhibit 52: Agilent Technologies Inc. – Business segments
Exhibit 53: Agilent Technologies Inc. – Organizational developments
Exhibit 54: Agilent Technologies Inc. – Geographic focus
Exhibit 55: Agilent Technologies Inc. – Segment focus
Exhibit 56: Agilent Technologies Inc. – Key offerings
Exhibit 57: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 58: Bio-Rad Laboratories Inc. – Business segments
Exhibit 59: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 60: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 61: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 62: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 69: Merck KGaA – Vendor overview
Exhibit 70: Merck KGaA – Business segments
Exhibit 71: Merck KGaA – Organizational developments
Exhibit 72: Merck KGaA – Geographic focus
Exhibit 73: Merck KGaA – Segment focus
Exhibit 74: Merck KGaA – Key offerings
Exhibit 75: New England Biolabs Inc. – Vendor overview
Exhibit 76: New England Biolabs Inc. – Product segments
Exhibit 77: New England Biolabs Inc. – Organizational developments
Exhibit 78: New England Biolabs Inc. – Key offerings
Exhibit 79: Promega Corp. – Vendor overview
Exhibit 80: Promega Corp. – Business segments
Exhibit 81: Promega Corp. – Key offerings
Exhibit 82: QIAGEN NV – Vendor overview
Exhibit 83: QIAGEN NV – Product segments
Exhibit 84: QIAGEN NV – Organizational developments
Exhibit 85: QIAGEN NV – Geographic focus
Exhibit 86: QIAGEN NV – Segment focus
Exhibit 87: QIAGEN NV – Key offerings
Exhibit 88: Takara Bio Inc. – Vendor overview
Exhibit 89: Takara Bio Inc. – Business segments
Exhibit 90: Takara Bio Inc. – Geographic focus
Exhibit 91: Takara Bio Inc. – Segment focus
Exhibit 92: Takara Bio Inc. – Key offerings
Exhibit 93: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 94: Thermo Fisher Scientific Inc. – Business segments
Exhibit 95: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 96: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 97: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 98: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 99: Validation techniques employed for market sizing
Exhibit 100: Definition of market positioning of vendors



【掲載企業】

Abcam Plc
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.

Merck KGaA

New England Biolabs Inc.

Promega Corp.
QIAGEN NV

Takara Bio Inc.

Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[分子量マーカーの世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆